JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

835.34 0.87

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

824.3

Max

835.92

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

24.813

60.328

Dividendenrendite

0.35

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+18.17% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.35%

2.24%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Juli 2026

Nächstes Ex-Dividendendatum

1. Juni 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

736M

106B

Vorheriger Eröffnungskurs

834.47

Vorheriger Schlusskurs

835.34

Nachrichtenstimmung

By Acuity

39%

61%

144 / 348 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Apr. 2026, 00:00 UTC

Ergebnisse

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24. Apr. 2026, 00:00 UTC

Ergebnisse

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23. Apr. 2026, 23:47 UTC

Market Talk

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23. Apr. 2026, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. Apr. 2026, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

23. Apr. 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23. Apr. 2026, 23:13 UTC

Akquisitionen, Fusionen, Übernahmen

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23. Apr. 2026, 22:33 UTC

Ergebnisse

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23. Apr. 2026, 22:17 UTC

Ergebnisse

PLS Executed Offtake Agreement With Ronbay

23. Apr. 2026, 22:17 UTC

Ergebnisse

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23. Apr. 2026, 22:16 UTC

Ergebnisse

PLS Commences Commissioning of Midstream Demonstration Plant

23. Apr. 2026, 22:15 UTC

Ergebnisse

PLS Group Reaffirms FY26 Guidance for All Metrics

23. Apr. 2026, 22:14 UTC

Ergebnisse

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23. Apr. 2026, 22:14 UTC

Ergebnisse

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23. Apr. 2026, 22:13 UTC

Ergebnisse

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23. Apr. 2026, 22:12 UTC

Ergebnisse

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23. Apr. 2026, 22:12 UTC

Ergebnisse

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23. Apr. 2026, 22:11 UTC

Ergebnisse

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23. Apr. 2026, 22:10 UTC

Ergebnisse

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23. Apr. 2026, 22:09 UTC

Ergebnisse

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23. Apr. 2026, 22:08 UTC

Ergebnisse

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23. Apr. 2026, 22:04 UTC

Ergebnisse

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23. Apr. 2026, 21:56 UTC

Market Talk
Ergebnisse

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23. Apr. 2026, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23. Apr. 2026, 21:27 UTC

Ergebnisse

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23. Apr. 2026, 21:25 UTC

Ergebnisse

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23. Apr. 2026, 21:24 UTC

Ergebnisse

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23. Apr. 2026, 21:24 UTC

Ergebnisse

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23. Apr. 2026, 21:21 UTC

Ergebnisse

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23. Apr. 2026, 21:21 UTC

Ergebnisse

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

18.17% Vorteil

12-Monats-Prognose

Durchschnitt 979.89 USD  18.17%

Hoch 1,107 USD

Tief 885 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

144 / 348 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat